Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach

Neuroradiology

Volumn 56, Issue 12, 2014, Pages 1031-1038

  Falk, Anna ^a   Fahlström, Markus ^a   Rostrup, Egill ^b   Berntsson, Shala ^a   Zetterling, Maria ^a   Morell, Arvid ^a   Larsson, Henrik B W ^b   Smits, Anja ^a   Larsson, Elna Marie ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dynamic contrast enhanced MRI; Dynamic susceptibility contrast MRI; Glioma; Histogram analysis; Perfusion MRI

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CANCER GRADING; CLINICAL ARTICLE; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST PERFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HISTOGRAM; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; MALE; PERFUSION WEIGHTED IMAGING; PROSPECTIVE STUDY; SUSCEPTIBILITY WEIGHTED IMAGING; BRAIN CIRCULATION; BRAIN TUMOR; COMPARATIVE STUDY; FUNCTIONAL NEUROIMAGING; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; YOUNG ADULT;

CONTRAST MEDIUM;

ADULT; AGED; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FUNCTIONAL NEUROIMAGING; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84911427110     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-014-1426-z     Document Type: Article

References (32)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. doi:10.1007/s00401-007-0243-4
2. Hartmann C, von Deimling A (2009) Molecular pathology of oligodendroglial tumors. Recent Results Cancer Res 171:25–49. doi:10.1007/1978-1003-1540-31206-31202_31202
3. Walker C, Baborie A, Crooks D, Wilkins S, Jenkinson MD (2011) Biology, genetics and imaging of glial cell tumours. Br J Radiol 84(2):S90–106. doi:10.1259/bjr/23430927
4. Fan GG, Deng QL, Wu ZH, Guo QY (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 79(944):652–658. doi:10.1259/bjr/25349497
5. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25(5):746–755
6. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP (2005) Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 26(2):266–273
7. Ostergaard L (2005) Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 22(6):710–717
8. Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D (2000) Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21(5):881–890
9. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K (2009) Quantification of cerebral blood flow, cerebral blood volume, and blood–brain-barrier leakage with DCE-MRI. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 62(1):205–217. doi:10.1002/mrm.22005
10. Larsson HB, Hansen AE, Berg HK, Rostrup E, Haraldseth O (2008) Dynamic contrast-enhanced quantitative perfusion measurement of the brain using T1-weighted MRI at 3 T. J Magn Reson Imaging 27(4):754–762. doi:10.1002/jmri.21328
11. Larsson HB, Courivaud F, Rostrup E, Hansen AE (2009) Measurement of brain perfusion, blood volume, and blood–brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 62(5):1270–1281. doi:10.1002/mrm.22136
12. Caseiras GB, Chheang S, Babb J, Rees JH, Pecerrelli N, Tozer DJ, Benton C, Zagzag D, Johnson G, Waldman AD, Jager HR, Law M (2010) Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. Eur J Radiol 73(2):215–220. doi:10.1016/j.ejrad.2008.11.005
13. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211(3):791–798
14. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24(10):1989–1998
15. Hilario A, Ramos A, Perez-Nunez A, Salvador E, Millan JM, Lagares A, Sepulveda JM, Gonzalez-Leon P, Hernandez-Lain A, Ricoy JR (2012) The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR Am J Neuroradiol 33(4):701–707. doi:10.3174/ajnr.A2846
16. Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S (2011) MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro-Oncology 13(4):447–455. doi:10.1093/neuonc/noq197
17. Khalid L, Carone M, Dumrongpisutikul N, Intrapiromkul J, Bonekamp D, Barker PB, Yousem DM (2012) Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol 33(5):852–857. doi:10.3174/ajnr.A2895
18. Saito T, Yamasaki F, Kajiwara Y, Abe N, Akiyama Y, Kakuda T, Takeshima Y, Sugiyama K, Okada Y, Kurisu K (2012) Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors. Eur J Radiol 81(8):1863–1869. doi:10.1016/j.ejrad.2011.1804.1009, Epub 2011 May 1864
19. 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neuro Oncol 114(2):241–249. doi:10.1007/s11060-013-1178-3
20. Tofts PS (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7(1):91–101
21. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27(4):859–867
22. Ostergaard L (2005) Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 22(6):710–717. doi:10.1002/jmri.20460
23. Calamante F, Gadian DG, Connelly A (2003) Quantification of bolus-tracking MRI: improved characterization of the tissue residue function using Tikhonov regularization. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 50(6):1237–1247. doi:10.1002/mrm.10643
24. Young R, Babb J, Law M, Pollack E, Johnson G (2007) Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 26(4):1053–1063. doi:10.1002/jmri.21064
25. Morita N, Wang S, Chawla S, Poptani H, Melhem ER (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32(4):803–808. doi:10.1002/jmri.22324
26. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 25(2):214–221
27. Cha S, Yang L, Johnson G, Lai A, Chen MH, Tihan T, Wendland M, Dillon WP (2006) Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 27(2):409–417
28. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S (2005) High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 60(4):493–502. doi:10.1016/j.crad.2004.09.009
29. Emblem KE, Nedregaard B, Nome T, Due-Tonnessen P, Hald JK, Scheie D, Borota OC, Cvancarova M, Bjornerud A (2008) Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247(3):808–817. doi:10.1148/radiol.2473070571
30. Scott CB, Nelson JS, Farnan NC, Curran WJ Jr, Murray KJ, Fischbach AJ, Gaspar LE, Nelson DF (1995) Central pathology review in clinical trials for patients with malignant glioma. A report of Radiation Therapy Oncology Group 83–02. Cancer 76(2):307–313
31. Battaglini M, Jenkinson M, De Stefano N (2012) Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 33(9):2062–2071. doi:10.1002/hbm.21344
32. Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE (2013) Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55(3):361–369. doi:10.1007/s00234-012-1127-4